Literature DB >> 17458678

Current survey of urinary tuberculosis in Hokkaido, Japan.

Satoshi Takahashi1, Koh Takeyama, Yasuharu Kunishima, Kohei Hashimoto, Shintaro Miyamoto, Kohji Ichihara, Yoshio Takagi, Toshiaki Tanaka, Takaoki Hirose, Ken-Ichi Sunaoshi, Fumiyasu Takei, Noriomi Miyao, Yuichiro Kurimura, Seiji Takagi, Taiji Tsukamoto.   

Abstract

Urinary tuberculosis has been rare in recent years and its diagnosis is difficult because there are no disease-specific symptoms. We tried to clarify the occurrence of urinary tuberculosis in recent years in our area. During the past 5 years, there were 12 patients with urinary tuberculosis in the clinics that participated in this study. Their chief complaints were frequent voiding in 7 patients and gross hematuria in 3 patients. They were diagnosed by nucleic acid amplification tests and imaging modalities such as excretory urography, computed tomography, and/or cystoscopy. Most of the patients received multidrug treatment and had relatively favorable treatment outcomes. There has been a small but neglected number of patients with urinary tuberculosis in recent years. We should keep this rare and difficult-to-diagnose disease in mind and suspect it when patients complain of longstanding urinary symptoms with no obvious cause.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17458678     DOI: 10.1007/s10156-006-0500-9

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  2 in total

1.  Incidence, etiopathogenesis and pathological aspects of genitourinary tuberculosis in India: A journey revisited.

Authors:  Prasenjit Das; Arvind Ahuja; Siddhartha Datta Gupta
Journal:  Indian J Urol       Date:  2008-07

2.  Serologic and urinary characteristics of laboratory-confirmed genitourinary tuberculosis at a tertiary hospital in the Philippines.

Authors:  Paolo Nikolai H So; Anthony Russell T Villanueva
Journal:  BMC Urol       Date:  2021-09-09       Impact factor: 2.264

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.